BioTech Agenus MAGE-A3 Vaccine Non-small Cell Lung Cancer Trial FailsBy Martin FloresMarch 31, 2014 Early this morning, GlaxoSmithKline (GSK $53.91) reported negative top-line results from its Phase III MARGIT trial with the MAGE-A3 vaccine…